​

Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?

OverviewForecastFinancialsChart

Kyverna Therapeutics Ownership Summary

Kyverna Therapeutics is owned by 66.89% institutional investors, 1.22% insiders, and 31.89% retail investors.

KYTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKyverna Therapeutics66.89%1.22%31.89%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202490-4.26%28,867,9802.72%661.58%5711.76%13-38.10%
Sep 30, 2024944.44%28,104,372-12.02%651.19%51-19.05%2190.91%
Jun 30, 202490-2.17%31,942,9114.22%740.44%63-29.21%11-
Mar 31, 202492-30,649,915-129-89---

Recent Insider Transactions

DateNameRoleActivityValue
Feb 12, 2024GILEAD SCIENCES, INC.-Buy$20.02M

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q11-
2022 Q3--

KYTX Ownership FAQ

Who Owns Kyverna Therapeutics?

Kyverna Therapeutics shareholders are primarily institutional investors at 66.89%, followed by 1.22% insiders and 31.89% retail investors. The average institutional ownership in Kyverna Therapeutics's industry, Biotech Stocks , is 68.48%, which Kyverna Therapeutics falls below.

Does Blackrock own Kyverna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kyverna Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools